Bradley Copeman
April 27 - 29, 2020 - Oxford GBOxford Global
d.dalby@oxfordglobal.co.uk
Phone:+44 1865 248455
Fax:+44 (0)1865 689120
Over 450 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions. Over 80 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing. View Agenda: https://bit.ly/2MU7dBq 27 April 2019 – Day One (Kick-Off Sessions) • Protein Engineering, Expression, Design & Selection • Bioanalysis: Characterisation, Stability Testing And Formulation Development • Biotherapeutics: Discovery & Development – Oncology & Immuno-Oncology 28 April 2020 – Day Two • Antibody Engineering, Screening, Design, Development • ADC Engineering, Bioconjugates and Fusion Proteins • Biotherapeutics: Discovery & Development – Oncology & Immuno-Oncology 29 April 2020 – Day Three • Antibody Engineering, Development & Generation (Part 1) and Biotherapeutics: Discovery & Development–Non-Oncology Indications (Part 2) • Bioanalysis: PKPD & Manufacturing • Biotherapeutics: Discovery & Development – Non-Oncology Indications PLUS: • Roundtable & Panel Discussions • Pre-Event Webinars